Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Inventory Average (2020 - 2025)

Burning Rock Biotech has reported Inventory Average over the past 6 years, most recently at $7.2 million for Q4 2025.

  • For Q4 2025, Inventory Average fell 14.47% year-over-year to $7.2 million; the TTM value through Dec 2025 reached $7.2 million, down 14.47%, while the annual FY2025 figure was $7.8 million, 15.16% down from the prior year.
  • Inventory Average for Q4 2025 was $7.2 million at Burning Rock Biotech, down from $7.9 million in the prior quarter.
  • Over five years, Inventory Average peaked at $20.3 million in Q3 2022 and troughed at $7.2 million in Q4 2025.
  • A 5-year average of $13.5 million and a median of $12.8 million in 2021 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: surged 81.27% in 2021 and later tumbled 47.5% in 2024.
  • Year by year, Inventory Average stood at $18.6 million in 2021, then rose by 5.99% to $19.7 million in 2022, then tumbled by 45.67% to $10.7 million in 2023, then dropped by 20.95% to $8.5 million in 2024, then dropped by 14.47% to $7.2 million in 2025.
  • Business Quant data shows Inventory Average for BNR at $7.2 million in Q4 2025, $7.9 million in Q3 2025, and $8.5 million in Q2 2025.